Last reviewed · How we verify
NCT04489693
Comprehensive Care Community and Culture Study
NA trial testing Ambulatory Care Coordinator Team (ACCT) in Comprehensive Care in 3,000 participants. Currently enrolling.
31 July 2027
Quick facts
| Lead sponsor | University of Chicago |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 3,000 |
| Start date | 6 March 2019 |
| Primary completion | 31 July 2027 |
| Estimated completion | 31 July 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Ambulatory Care Coordinator Team (ACCT)
- Comprehensive Care Physician Program (CCP)
- Comprehensive Care Community & Culture Program (C4P)
Conditions studied
- Comprehensive Care — all drugs for Comprehensive Care →
- Quality of Care — all drugs for Quality of Care →
- Medicare — all drugs for Medicare →
- Cost of Care — all drugs for Cost of Care →
Sponsor
University of Chicago
Who can join
18 and older, any sex, with Comprehensive Care or Quality of Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized trial is evaluating whether socioeconomically disadvantaged Medicare patients at increased risk of hospitalization experience fewer hospitalization if those patients are offered care in: 1) ACCT, where patients receive care from different physicians in the hospital and the clinic settings and have access to nurse and social worker care coordination services, 2) CCP where patients receive care from one physician in the inpatient and outpatient settings or 3) C4P which adds screening of unmet social needs, community health worker support and arts and culture programming to CCP. The study will determine how these programs affect patient activation and engagement in care, satisfaction with care, general health and mental health, and goal attainment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinician experiences in a DBT-informed consultation group embedded within a US academic primary care clinic: a qualitative study.
Gier NM, Maurer RR, Tang JW. · · 2025 · PMID 41145263 · DOI 10.1136/bmjopen-2025-100967
Verify or expand the search:
- PubMed search for NCT04489693
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Chicago trials
Trials by the same sponsor.
- NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
- NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
- NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
- NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
- NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04489693 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Chicago
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489693.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing